Biomarkers, including CSF Aβ42/Aβ40, p-Tau181, t-Tau, and neurofilament light chains (NfL), can facilitate the early diagnosis of AD-related MCI and monitor disease progression (Chatterjee et al., 2023). The gene discussed is NEFL; the disease is Alzheimer disease.